Reports for TAKEDA CANADA INC
Company Name
TAKEDA CANADA INC
Totals |
||
Shortage reports |
53 |
|
Actual shortage: | 0 (0%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 53 (100%) | |
Discontinuation Reports |
10 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 10 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
FEIBA NF | 1300UNIT | POWDER FOR SOLUTION KIT | Resolved | 2021-02-25 | 2021-04-12 | 134686 |
FEIBA NF | 1300UNIT | KIT POWDER FOR SOLUTION | Resolved | 2021-06-04 | 2021-06-25 | 140472 |
GAMMAGARD S/D | 5G | KIT SOLUTION POWDER FOR SOLUTION | Resolved | 2023-08-23 | 2023-09-14 | 202833 |
GAMMAGARD S/D | 5G | KIT SOLUTION POWDER FOR SOLUTION | Resolved | 2023-10-18 | 2024-01-31 | 207306 |
ANTITHROMBIN III NF | 1100UNIT | KIT POWDER FOR SOLUTION | Resolved | 2020-11-13 | 2020-12-02 | 128404 |
ADDERALL XR | 5.00MG 5.00MG 5.00MG 5.00MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-02-01 | 2019-02-08 | 74152 |
ADDERALL XR | 5.00MG 5.00MG 5.00MG 5.00MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-03-07 | 2019-03-09 | 77992 |
ADDERALL XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-04-21 | 2022-05-05 | 159220 |
TECTA | 40MG | TABLET (ENTERIC-COATED) | Resolved | 2018-07-31 | 2018-09-21 | 57003 |
TECTA | 40MG | TABLET (ENTERIC-COATED) | Resolved | 2019-02-21 | 2019-06-11 | 76478 |
TECTA | 40MG | TABLET (ENTERIC-COATED) | Resolved | 2020-11-16 | 2021-01-22 | 128447 |
GAMMAGARD LIQUID | 10% | SOLUTION | Resolved | 2019-07-31 | 2020-02-06 | 90434 |
FOSRENOL | 250MG | TABLET (CHEWABLE) | Resolved | 2018-06-04 | 2018-07-14 | 51338 |
FOSRENOL | 250MG | TABLET (CHEWABLE) | Resolved | 2020-05-25 | 2021-02-12 | 115725 |
FOSRENOL | 500MG | TABLET (CHEWABLE) | Resolved | 2019-01-15 | 2019-01-26 | 72349 |
ELAPRASE | 2MG | SOLUTION | Resolved | 2019-04-29 | 2019-05-02 | 82729 |
MEZAVANT | 1.2G | TABLET (DELAYED AND EXTENDED RELEASE) | Resolved | 2020-01-15 | 2020-08-22 | 103353 |
MEZAVANT | 1.2G | TABLET (DELAYED AND EXTENDED RELEASE) | Resolved | 2022-07-18 | 2022-08-19 | 164835 |
MEZAVANT | 1.2G | TABLET (DELAYED AND EXTENDED RELEASE) | Resolved | 2022-10-14 | 2022-11-02 | 171844 |
VYVANSE | 30MG | CAPSULE | Resolved | 2021-12-02 | 2021-12-12 | 150417 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
AGRYLIN | 0.5MG | CAPSULE | Discontinued | 2023-11-14 | 2024-03-01 | 210182 |
PANTO IV | 40MG | POWDER FOR SOLUTION | Discontinued | 2017-03-15 | 2017-03-15 | 2969 |
ACTOS | 15MG | TABLET | Discontinued | 2018-04-02 | 2018-04-02 | 44428 |
ACTOS | 30MG | TABLET | Discontinued | 2018-04-02 | 2018-04-02 | 44433 |
ACTOS | 45MG | TABLET | Discontinued | 2018-04-02 | 2018-04-02 | 44438 |
FOSRENOL | 250MG | TABLET (CHEWABLE) | Discontinued | 2022-12-19 | 2023-04-30 | 178916 |
FOSRENOL | 500MG | TABLET (CHEWABLE) | Discontinued | 2024-05-16 | 2024-06-10 | 228178 |
FOSRENOL | 750MG | TABLET (CHEWABLE) | Discontinued | 2024-05-16 | 2024-08-01 | 228181 |
FOSRENOL | 1000MG | TABLET (CHEWABLE) | Discontinued | 2024-05-16 | 2024-08-01 | 228184 |
ULORIC | 80MG | TABLET | Discontinued | 2021-08-17 | 2022-01-04 | 144266 |
Showing 1 to 10 of 10